comparemela.com

Latest Breaking News On - Maxcyte - Page 14 : comparemela.com

Investegate |MaxCyte, Inc Announcements | MaxCyte, Inc : Establishment of New Scientific Advisory Board

Investegate announcements from MaxCyte, Inc., Establishment of New Scientific Advisory Board

New yorkUnited statesMemorial sloan kettering cancer centerMassachusetts institute of technologyUnited kingdomJerry crabtreeDavid deuchlerTom maniatisDoug doerflerLos angelesMarcela mausAnne andrewsAvery poseyPanmure gordonTheposey labfocusesNako nakatsuka

Investegate |MaxCyte, Inc Announcements | MaxCyte, Inc : Preliminary Unaudited Q4 &FY 2022 Revenue Results

Investegate announcements from MaxCyte, Inc., Preliminary Unaudited Q4 &FY 2022 Revenue Results

United kingdomDavid deuchlerDoug doerflerMary jane elliott chris welshEmma earl freddy crossleyPanmure gordonRupert deardenMaxcyte incVertex pharmaceuticalsExchange commission onA spectrum science companyExchange commissionGilmartin groupConsilium strategic communicationsFull yearCatamaran bio

MaxCyte revenue grows in 2022, expects further revenue climb in 2023

MaxCyte Inc on Tuesday announced a higher revenue for 2022, and said it anticipates revenue to grow further during 2023. The Maryland, US-based commercial cell-engineering company with an office in. | March 7, 2023

United statesTom budszusDoug doerflerVertex pharmaceuticalsAlliance news ltdMaxcyte inc onAlliance newsCyte incChief executive officer dougAll rightsNc stock exchangePress releaseFfice mxct us57777k1060

Investegate |MaxCyte, Inc Announcements | MaxCyte, Inc : Notice of Results

Investegate announcements from MaxCyte, Inc., Notice of Results

United kingdomDavid deuchlerMary jane elliott chris welshPanmure gordonEmma earl freddy crossleyRupert deardenMaxcyte incDigital healthGilmartin groupConsilium strategic communicationsReport fourth quarterFull yearUpcoming investorLife scienceDiagnostic toolsAnnual cowen healthcare

Investegate |MaxCyte, Inc Announcements | MaxCyte, Inc : Exercise of options and PDMR dealing

Investegate announcements from MaxCyte, Inc., Exercise of options and PDMR dealing

United kingdomCity ofDavid deuchlerChris welshMary jane elliottDoug doerflerEmma earl freddy crossleyPanmure gordonRupert deardenMaxcyte incLondon stock exchangeGilmartin groupCompany common stockConsilium strategic communicationsTotal votingChief executive officer

vimarsana © 2020. All Rights Reserved.